Outcome of cadaveric renal transplant patients treated for 10 years with cyclosporine: Is chronic allograft nephropathy the major cause of late graft loss?

Transplantation

Volumn 72, Issue 1, 2001, Pages 57-62

  Marcén, Roberto ^a,b   Pascual, Julio ^a,b   Teruel, José Luis ^a,b   Villafruela, Juan José ^a,b   Rivera, Maite Elizabeth ^a,b   Mampaso, Francisco ^a,b   Burgos, Francisco Javier ^a,b   Ortũeo, Joaquín ^a,b  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN A;

ADULT; ARTICLE; CADAVER KIDNEY; CREATININE BLOOD LEVEL; FEMALE; GRAFT SURVIVAL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERURICEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; SURVIVAL;

ADULT; AZATHIOPRINE; CADAVER; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PREDNISONE; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0035879164     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200107150-00013     Document Type: Article

References (42)

1. A randomized clinical trial of cyclosporine and cadaver renal transplantation
2. Cyclosporine: Five years' experience in cadaveric renal transplantation
3. Cyclosporin in cadaveric renal transplantation: 3-year follow-up of a European Multicentre Trial
4. A single institution, randomized, prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients
5. Cyclosporine (Sandimmun) in cadaveric renal transplantation
6. Long-term benefits and risk of cyclosporin A (Sandimmun): An analysis at 10 years
7. Randomized study with cyclosporine in kidney transplantation: 10-year follow-up
8. Chronic renal allograft function under cyclosporin treatment
9. Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy
10. Should cyclosporine be continued indefinitely?
11. Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantation
12. Elective cyclosporine withdrawal after renal transplantation: A meta-analysis
13. The impact of azathioprine and cyclosporine on long-term function in kidney transplantation
14. Long-term renal allograft function under maintenance immunosuppression with cyclosporin A or azathioprine: A single center, five-year follow-up study
15. Stability of renal allograft glomerular filtration rate associated with long-term use of cyclosporine A
16. Renal transplant function after ten years of cyclosporine
17. Long-term efficacy and safety of cyclosporine in renal-transplant recipients
18. Effect of cyclosporine on renal function in kidney transplant recipients: A 12-year follow-up
19. Long-term maintenance of therapeutic cyclosporine levels leads to optimal graft survival without evidence of chronic nephrotoxicity
20. The clinical status of cadaveric renal transplant patients treated for 10 years with cyclosporine therapy
21. Evidence that addition of azathioprine improves renal function in cyclosporine treated patients with allograft dysfunction
22. Diagnostic criteria for chronic rejection/accelerated graft atherosclerosis in heart and kidney transplants: Joint proposal from the Fourth Alexis Carrel Conference on chronic rejection and accelerated arteriosclerosis in transplanted organs
23. Factors affecting long-term renal allograft survival in cyclosporine-treated kidney transplants
24. Improved graft survival after renal transplantation
25. Causes of renal allograft loss: Progress in the 1980s, challenge for the 1990s
26. Causes of renal allograft loss in black vs white transplant recipients in the cyclosporine era
27. Time dependency of factors affecting renal allograft survival
28. Report on management of renal failure in Europe XXII, 1991
29. Limitations of creatinine in quantifying the severity of cyclosporine-induced chronic nephropathy
30. Measurements of true glomerular filtration rate in renal transplant patients receiving cyclosporine
31. Oral cimetidine improves the accuracy of creatinine clearance in transplant patients on cyclosporine
32. Hypertension after renal transplantation: A comparison of cyclosporine and conventional immunosuppression
33. The role of hypertension as a damaging factor for kidney grafts under cyclosporine therapy
34. Hypertension after renal transplantation
35. The adverse impact of cyclosporine on serum lipids in renal transplant recipients
36. Independent effects of cyclosporine and prednisone on posttransplant hypercholesterolemia
37. Late prednisone withdrawal in cyclosporine-treated kidney transplant patients: A randomized study
38. Impairment of tubular secretion of urate in renal transplant patients on cyclosporin
39. Hyperuricemia in cyclosporin-treated patients: A GFR-related effect
40. Cardiovascular disease after renal transplantation
41. Relationship between steroids dosage and osteonecrosis of the femoral head after renal transplantation as measured by magnetic resonance imaging
42. Incidence and long-term cost of steroid-related side effects after renal transplantation